# Chinese expert consensus on the diagnosis and management of nodal peripheral T-cell lymphoma (2025)

## TL;DR

This paper presents a Chinese expert consensus on diagnosing and managing nodal peripheral T-cell lymphoma, a common and aggressive lymphoma in China.

## Contribution

The paper introduces a new expert consensus to standardize diagnosis and treatment of nodal PTCL in China.

## Key findings

- Nodal PTCL is the most common PTCL in China, with high aggressiveness and poor prognosis.
- Targeted therapies and combination strategies are improving outcomes and changing treatment approaches.
- The consensus aims to promote standardized clinical practices and research into new therapies.

## Abstract

外周T细胞淋巴瘤（peripheral T-cell lymphomas, PTCL）是我国常见的非霍奇金淋巴瘤，发病率高于西方国家。除结外NK/T细胞淋巴瘤外，我国最常见的PTCL是淋巴结PTCL。淋巴结PTCL多数侵袭性强、预后差，各亚型分子特征和临床表现差异大，传统化疗疗效有限。近年来靶向药物以及多药联合治疗策略的应用显著改善了部分患者的预后，也正在改变患者的初始、维持及复发后治疗模式。基于此，中国临床肿瘤学会（CSCO）淋巴瘤专家委员会和中华医学会血液学分会淋巴细胞疾病学组组织相关专家制定了本共识，旨在推动我国临床医师对淋巴结PTCL的进一步规范诊疗及新型疗法的临床研究和应用。